Vectura Share Discussion Threads

[polaris] 17/10/2020 22:59

I don't subscribe to law360.com.

[peddlers] 15/10/2020 20:18

Nice Institutional buys which explains the massive volumes.
This is a good confidence booster.
Not to mention the broker forecast price of circa 130, which will likely be upgraded given the growth in this sector, coupled with renowned investors buys such as Robbie Burns who has added numerous positions.
Buy at these prices while you still can, and buy, or add on the pullbacks as we head up.

P

[base7] 15/10/2020 18:05

If there has been a seller ,suppressing our share price ,perhaps they have now sold out .Our track record with Vec suggests there will be little market reaction but will be interesting

[peddlers] 13/10/2020 17:10

I was feeling flush.

thats me holding 10,210,000 now :-)

P

[peddlers] 13/10/2020 17:02

2 Ordinary trades ( 5.1M each) went through at quarter to 4

[bobo18] 13/10/2020 16:33

Huge volume today - any rumours or news bubbling up?

[peddlers] 13/10/2020 13:41

I have heared in the past few days that the hospitals are inundated with cases but it is being greatly played down vs March

[srpactive] 13/10/2020 13:36

p

Yes it looks very strong, I cannot understand why this is not surging higher,
when the virus is based on respiratory problems, using the inhaler will
be in high demand now than before covid started, no?

[peddlers] 13/10/2020 13:22

Chart is looking good.

Might get a buying opportunity in the next few days.

[base7] 13/10/2020 08:59

We arent expecting to hear any more about our Advair Generic or case v GSK until early ( ish) next year ,unless, presumably, the Judges decide that a retrial should happen,in which case we may hear that (bad ) news sooner.
Meanwhile, our other major JV with Hikma should be making progress & we will hopefully soon hear what the submission timetable is expected to be together with news on any collaborations/partnerships regarding the likelihood of our involvement in any C-19 solutions( we have 2 Directors who are non execs of Novact & Avacta)
There must also be the possibility of Corporate action ( apart from options/rewards to our new senior management team ) , perhaps a bolt on acquisition to expand our involvement in the CDMS arena.
Ever hopeful !

[justiceforthemany] 12/10/2020 22:58

Vectura Limited v. GlaxoSimthKline LLC, No. 20-1054

This case involves U.S. Patent No. 8,303,991, relating to composite active particles comprising particles of active material and an additive material (e.g., magnesium stearate (“MgSt”)) on the surface of the particles. An asserted claim further requires that the additive material promotes the dispersion of the active particles upon actuation of a delivery device. Vectura filed suit alleging that GSK infringed the claim, and the jury found infringement. GSK then moved for judgement as a matter of law or a new trial, arguing that Vectura had not presented sufficient evidence that GSK’s accused products practiced the “dispersion221; limitation of the claim. The court rejected the argument.

GSK asserts on appeal that it is entitled to judgment of noninfringement as a matter of law because experimentation by Vectura was required to prove that coating the active particles with MgSt improved dispersion, compared to products in which only carrier particles were coated with MgSt. GSK argues that Vectura conducted no dispersion tests on GSK’s accused products but merely extrapolated from a 2006 study of different experimental blends. According to GSK, in relying on the study, Vectura fails to meet its burden of proof because the experimental blends are not representative of GSK’s accused products. GSK also asserts that its products are made by a different method and contain ingredients absent from the study. In response, Vectura argues that no experimentation was required to prove infringement. According to Vectura, GSK itself conducted the study for testing the benefit to dispersal by coating the active particles and the carrier particles with MgSt. Vectura further asserts that the study showed that coating both types of particles with MgSt provided a three-fold increase in dispersion, as compared to coating only the carrier particles. Vectura claims that GSK itself concluded based on the study that the active particles “must be coated” with MgSt. According to Vectura, these asserted facts constitute substantial evidence of infringement. Vectura also argues that, in any event, GSK’s arguments about the differences between the study and the accused products were either fully presented to the jury and rejected, or never raised and therefore waived.

hxxps://www.finnegan.com/en/insights/blogs/federal-circuit-ip/spotlight-on-upcoming-oral-arguments-october-2020.html#page=1

[justiceforthemany] 12/10/2020 22:54

x2 446,758 'off book' trades today at the offer price 106.2p suggesting buys.

[srpactive] 12/10/2020 10:22

Another one trade, news soon possibly.

[srpactive] 12/10/2020 09:08

a53

Very good find, looks promising, we have a 1 trade so hopefully
more news soon, the gsk outcome?

dyor

[a1ord53] 11/10/2020 22:47

Inhaled Vaccines Aim to Fight Coronavirus at Its Point of Attack:

[pooroldboy55] 10/10/2020 09:15

Ah peddlers
At my age just waking up in the the morning is positive for me .Yes do try to put some humour in at times don't do any analytical stuff as assume we all do our own research.
Have a good weekend
POB (Andrew )

[peddlers] 09/10/2020 23:13

Poorold - Crikey lol, Are you having a bad day or is there a dark sense if humour in there? Stay positive old sport, this company is going up and you're going up with it.

P

[polaris] 09/10/2020 20:19

It was the bottom of the channel after all this week. I had to cancel my buy orders due to the Armenia-Azerbaijan conflict hurting my AAZ position and taking my spare margin. Traders will be looking to exploiting the range 100-120 p, IMO.

[dp1umb] 09/10/2020 19:31

What was the outcome of this weeks judicial review?

[pooroldboy55] 09/10/2020 19:16

This does seem to happen on Fridays for some reason don't worry usually disappears early Monday, but of course this time could be different.

[base7] 09/10/2020 17:28

Unexpectedly firm close on average volume -most welcome ahead of the weekend

[peddlers] 09/10/2020 15:40

Tempted to add here

[srpactive] 09/10/2020 09:15

I do not know why gsk do not offer 130p to buy vec, then pay
themselves the $200m. So it would be like buying vec for 100pps.

dyor

active